In preclinical studies, 5-FU has been shown to increase expression of carcinoembryonic antigen (CEA) in breast cancer cell lines (153) and reduce the number of myeloid derived suppressor cells (MDSCs) in murine models (154). Here, CEACAM5 is linked to breast cancer.